controversial

Europe is changing its assessment and giving limited approval to lecanemab, a controversial Alzheimer’s disease drug.

The European Medicines Agency (EMA) has re-evaluated the Alzheimer's drug lecanemab and decided to authorize the product. The decision comes…

1 week ago

Lisandro Borges, the controversial promoter who disrupted the padel tennis industry and sued Rafa Nadal for $10 million | Relief

The world of padel tennis is once again in the spotlight due to controversy. On this occasion it was clear…

2 months ago